Sederma introduces Matrixyl inside branding programme
Intel inside style approach for cosmetic ingredient
“The Matrixyl brand is known worldwide, its name being synonymous with ‘efficacy’ and ‘reliability’ in fighting ageing signs. It is one of the rare ingredient names that is known by end users and which benefit from their recognition,” says Sederma. “So what about using this renown and make it clearly appear on the end product that it contains an ingredient from the Matrixyl range?”
Earlier this year Sederma added Matrixylsynthe’6 to the line, designed to redensify the dermal tissue by stimulating six major constituents of the skin matrix and the dermal–epidermal junction (DEJ). And more recently new proof of efficacy data for Matrixyl 3000 has been released, indicating an ability to help repair the UV damage-prone papillary dermis, demonstrated with an improvement corresponding to a gain in youth of 1.8 years in just one month.
“Any end product containing an ingredient from the Matrixyl range (conditions apply) can benefit from this cutting–edge ingredient branding programme,” says Sederma.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Why ginger could be the secret to tackling undereye dark circles
Read moreSederma's Ameyezing 4.0 counteracts both vascular and hyperpigmented dark circles, as Pascaline Criton, Marketing Communications Manager at Sederma, explains
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.